Approval · Notice of Compliance 2227 · 2001
VANIQA: Notice of Compliance 2227
Issued May 10, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2227
- Date
- May 10, 2001
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Hair growth inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VANIQA | 02243837 | Marketed |
Medicinal ingredients
- EFLORNITHINE HYDROCHLORIDE 13.9 PER